2024-09-20 - Analysis Report
## Pfizer Inc. (PFE) Stock Analysis

**Company Overview:** Pfizer Inc. is a multinational pharmaceutical corporation that develops and manufactures medicines and vaccines.

**Performance Comparison:**
* **Cumulative Return:** -10.64%
* **S&P 500 (VOO) Cumulative Return:** 128.99%
* **Return Difference:** -139.63%
* **Relative Divergence:** 2.54% (This means the stock's performance is currently in the bottom 2.54% of its historical performance range relative to the S&P 500) 

**Recent Price Movements:**
* **Closing Price:** $29.75
* **5-day Moving Average:** $29.59
* **20-day Moving Average:** $29.07
* **60-day Moving Average:** $29.07

**Technical Indicators:**
* **RSI:** 61.52 (indicates neither overbought nor oversold conditions)
* **PPO:** 0.41 (suggests potential for upward momentum)
* **Delta_Previous_Relative_Divergence:** 0.82 (-) (indicates a short-term downward trend)
* **Expected Return:** 14.86% (potential 5-year return based on current investment amount)

**Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-07-30 | 0.6 | 0.458 |
| 2024-05-01 | 0.82 | 0.516 |
| 2024-01-30 | 0.1 | -0.19 |
| 2023-10-31 | -0.17 | -0.32 |
| 2023-08-01 | 0.67 | 0.56 |

**Analysis of Recent Earnings:** 
Pfizer's recent earnings have been mixed. The company has consistently exceeded expectations for the past two quarters (2024-05-01 and 2024-07-30). However, earnings have been inconsistent over the past year, with the Q4 2023 earnings showing a decline. 

**Overall Analysis:**
Pfizer has underperformed the market significantly over the long term, lagging behind the S&P 500 by a considerable margin. While recent earnings have been positive, the stock's performance is currently in the bottom 2.54% of its historical range relative to the S&P 500. Short-term indicators suggest a potential downward trend, although the PPO indicator points to potential upward momentum. With an expected return of 14.86%, investors may want to consider the long-term potential of Pfizer while acknowledging the recent underperformance and potential short-term downward trend. 
